Skip to main content

Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name NCATS Issued FOA Number Activity Code Posting Date Expiration Date Opportunity Type
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) PAR-25-296 UG3/UH3 12/11/2024 10/19/2027 NA
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) PAR-25-155 R03 12/11/2024 10/19/2026 NA
Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed) PAR-25-197 R25 12/09/2024 05/28/2027 NA
Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) PAR-25-157 R21 12/10/2024 06/18/2026 NA
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) RFA-TR-25-002 R21 12/06/2024 06/02/2026 NA
Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) NOT-OD-24-179 Admin Supp 10/11/2024 09/08/2025 Notice of Special Interest
Notice of Participation of the National Center for Advancing Translational Sciences (NCATS) in NOT-OD-24-179, "Notice of Special Interest (NOSI): Research on the Health of Women of Underrepresented, Underserved, and Underreported (U3) Populations" NOT-TR-25-003 11/25/2024 Notice of Information
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) PAR-25-217 R21 11/20/2024 10/02/2025 NA
Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) PAR-25-220 R21 11/20/2024 10/02/2025 NA
NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional) RFA-HL-26-015 R44 11/18/2024 02/26/2027 NA
Showing Row 21 to 30 of 415

Last updated on February 19, 2025